Jury Still Out On Success Of FDA's Warning Letter Close-Out Program
This article was originally published in The Gray Sheet
Executive Summary
FDA is extending its warning letter "close-out" pilot program to learn more about its value, even as grumblings begin that the program may not be all it was cracked up to be.